SCHEMBL6809858

SCHEMBL6809858

NC(=O)CC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.49
ALOX15 P16050 2/20 0.49
BLM P54132 2/20 0.49
PMP22 Q01453 1/20 0.49
PTGS1 P23219 1/20 0.48
GSTK1 Q9Y2Q3 1/20 0.48
DPP4 P27487 2/20 0.48
DPP8 Q6V1X1 2/20 0.48
DPP9 Q86TI2 2/20 0.48
FOLH1 Q04609 2/20 0.47
ACE P12821 1/20 0.42
NOD1 Q9Y239 1/20 0.41
CA2 P00918 4/20 0.40
CA1 P00915 3/20 0.40
RIMKLA Q8IXN7 1/20 0.39
NAALAD2 Q9Y3Q0 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809847 1.00 KMT2A (0.49) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL6806093 0.98 KMT2A (0.47) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL6806102 0.98 KMT2A (0.47) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL6810621 0.96 FOLH1 (0.55) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL30198445 0.96 FOLH1 (0.55) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL7461972 0.96 FOLH1 (0.55) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL6810612 0.96 FOLH1 (0.55) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL29420040 0.95 ALOX15 (0.50) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL6809811 0.94 FOLH1 (0.54) KMT2AALOX15BLMPMP22PTGS1
SCHEMBL6809803 0.94 FOLH1 (0.54) KMT2AALOX15BLMPMP22PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040018983-A1 Antifungal compositions ACHILLION PHARMACEUTICALS, INC. 2004-01-29 US claimed
WO-2003055448-A2 ANTIFUNGAL COMPOSITIONS ACHILLION PHARMACEUTICALS, INC. (US) 2003-07-10 WO claimed
US-20040018983-A1 Antifungal compositions ACHILLION PHARMACEUTICALS, INC. 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040018983-A1 Antifungal compositions CNBP, ERG28, AEBP2 KMT2A 3788/4885ALOX15 2954/4885BLM 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.